Kalaris Therapeutics, Inc. (ALVR) at a glance

Kalaris Therapeutics, Inc. (ALVR) is a micro-cap Healthcare company. It trades at $4.4. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Momentum (29/100).

Price
$4.40
Market cap
$21.2M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$2.14 to $11.88
Vestovix Score49/ 100How this works
Value
50
Growth
50
Income
40
Safety
66
Momentum
29

Other Healthcare stocks

See all